Which companies are affected
Some muscle loss can occur during rapid weight reduction, especially with low protein intake
However, it should be prescribed as part of a comprehensive treatment plan tailored to the individual
Being Patient: The research is obviously coming in, and theres more data to be found
What the Evidence Shows on Compounded Bioidentical HRT The Menopause Society (formerly NAMS) published a 2020 position statement noting: "Compounded bioidentical hormone therapy (cBHT) is not recommended over FDA-approved bioidentical hormone therapy due to concerns about safety, quality, and the lack of clinical trial data." [11] That position reflects the absence of randomized controlled trials powered to show efficacy or long-term safety for compounded formulations specifically, not for the hormones themselves
Key findings Around 71,600 Danes (2.6% of those aged 45 years) would be eligible for semaglutide Nationwide implementation could potentially prevent approximately 458 major cardiovascular events annually The estimated number needed to treat was 156 patients per year to prevent one cardiovascular event Why it matters The SELECT trial changed the conversation around obesity treatment by demonstrating cardiovascular benefit beyond weight loss
